HighTower Advisors
PRVL

HighTower Advisors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

HighTower Advisors’s Portfolio PRVL Stock Details PRVL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,130,000
Closed -$11.5M – 2727
2020
Q3 		$11.5M Buy
+1,130,000
New +$11.5M 0.06% 310